Showing results (271-280 of 289) with videos related to
Sort By:
Pageof 29
AIDS Research and Human Retroviruses|October 6, 2000
Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cellsC M Gray, J Lawrence, E A Ranheim, et al.The New England Journal of Medicine|April 22, 1993
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infectionP M Small, R W Shafer, P C Hopewell, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Genotypic correlates of a virologic response to stavudine after zidovudine monotherapyN S Shulman, R A Machekano, R W Shafer, et al.AIDS (London, England)|June 21, 2001
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapyN Shulman, A R Zolopa, D Passaro, et al.Circulation|July 7, 1999
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled studyH A Valantine, S Z Gao, S G Menon, et al.The New England Journal of Medicine|October 10, 1996
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamD A Katzenstein, S M Hammer, M D Hughes, et al.Antimicrobial Agents and Chemotherapy|February 19, 2000
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)L M Demeter, R W Shafer, P M Meehan, et al.Annals of Internal Medicine|July 1, 1982
Cytomegalovirus immune plasma in bone marrow transplant recipientsD J Winston, R B Pollard, W G Ho, et al.The Pharmacogenomics Journal|August 9, 2007
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathyJ A Canter, D W Haas, A R Kallianpur, et al.The Journal of Infectious Diseases|April 1, 1994
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutationsR W Shafer, M J Kozal, M A Winters, et al.Pageof 29